Aastrom Biosciences Income Statement
View: Annual | Quarterly
| Jun 07 | Jun 06 | Jun 05 | |
|---|---|---|---|
| Revenue | 0.7 | 0.9 | 0.9 |
| Cost of Goods Sold | 0.0 | 0.0 | 0.2 |
| Gross Profit | 0.7 | 0.9 | 0.8 |
| Gross Profit Margin | 95.6% | 98.8% | 83.5% |
| SG&A Expense | 20.2 | 18.4 | 13.1 |
| Depreciation & Amortization | (0.1) | 0.2 | 0.1 |
| Operating Income | (19.5) | (17.7) | (12.4) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 1.9 | 1.3 | 0.6 |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | (17.6) | (16.5) | (11.8) |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | (17.6) | (16.5) | (11.8) |
| Continuing Operations | (17.6) | (16.5) | (11.8) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (17.6) | (16.5) | (11.8) |
| Total Net Income | (17.6) | (16.5) | (11.8) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.15) | (0.15) | (0.13) |
| Dividends per Share | -- | -- | -- |






